UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
- De Lago, E.
- Fernández-Ruiz, J.
- Ortega-Gutiérrez, S.
- Cabranes, A.
- Pryce, G.
- Baker, D.
- López-Rodríguez, M.
- Ramos, J.A.
ISSN: 0924-977X
Year of publication: 2006
Volume: 16
Issue: 1
Pages: 7-18
Type: Article